These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8239228)

  • 1. Interferon-alpha 2b: a new treatment for polycythemia vera.
    Silver RT
    Ann Intern Med; 1993 Dec; 119(11):1091-2. PubMed ID: 8239228
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant interferon alpha-2b in the treatment of polycythemia vera.
    Cimino R; Rametta V; Matera C; Mele G; Mettivier V; Ferrara F
    Am J Hematol; 1993 Nov; 44(3):155-7. PubMed ID: 8213763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible selective effects of interferon alpha-2b on a malignant clone in a case of polycythemia vera.
    Hino M; Futami E; Okuno S; Miki T; Nishizawa Y; Morii H
    Ann Hematol; 1993 Mar; 66(3):161-2. PubMed ID: 8471662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal management of polycythaemia vera.
    Spivak JL
    Br J Haematol; 2002 Feb; 116(2):243-54. PubMed ID: 11841424
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera.
    Foa P; Massaro P; Caldiera S; LaTargia ML; Iurlo A; Clerici C; Fornier M; Bertoni F; Maiolo AT
    Eur J Haematol; 1998 May; 60(5):273-7. PubMed ID: 9654155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa.
    Finelli C; Gugliotta L; Gamberi B; Vianelli N; Visani G; Tura S
    Am J Hematol; 1993 Aug; 43(4):316-8. PubMed ID: 8372816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interferon alpha-2a in the treatment of polycythemia vera.
    Foa P; Massaro P; Ribera S; Iurlo A; Mezzanotte C; Giandalia D; Maiolo AT
    Am J Hematol; 1995 Jan; 48(1):55-7. PubMed ID: 7832194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.
    Melikyan AL; Subortseva IN; Gilyazitdinova EA; Koloshejnova TI; Pustovaya EI; Egorova EK; Kovrigina AM; Sudarikov AB; Abdullaev AO; Lomaia EG; Siordiya NT; Zaritskey AY; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):23-29. PubMed ID: 30701919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2a.
    Merup M; Törnebohm-Roche E; Engman K; Paul C
    Eur J Cancer; 1994; 30A(11):1729-30. PubMed ID: 7833154
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant alpha 2a interferon and polycythemia vera: clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy.
    Papineschi F; Bucalossi A; Capochiani E; Benedetti E; Bramanti E; Dastoli G; Dispensa E; Benedetti E; Spremolla G
    Eur J Haematol; 1994 Oct; 53(4):213-7. PubMed ID: 7957805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy.
    Gilbert HS
    Cancer; 1998 Sep; 83(6):1205-13. PubMed ID: 9740087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera.
    Wagner SM; Melchardt T; Greil R
    Drugs Today (Barc); 2020 Mar; 56(3):195-202. PubMed ID: 32282866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycythemia vera treated with recombinant interferon-alpha 2a: evidence of a selective effect on the malignant clone.
    Massaro P; Foa P; Pomati M; LaTargia ML; Iurlo A; Clerici C; Caldiera S; Fornier M; Maiolo AT
    Am J Hematol; 1997 Oct; 56(2):126-8. PubMed ID: 9326356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera.
    Kiladjian JJ; Cassinat B; Chevret S; Turlure P; Cambier N; Roussel M; Bellucci S; Grandchamp B; Chomienne C; Fenaux P
    Blood; 2008 Oct; 112(8):3065-72. PubMed ID: 18650451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon antibodies in thrombocythemia.
    Merup M; Engman K; Paul C
    J Interferon Res; 1994 Aug; 14(4):187-9. PubMed ID: 7822871
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of the treatment of polycythemia vera with recombinant interferon-alpha.
    Silver RT
    Cancer; 2006 Aug; 107(3):451-8. PubMed ID: 16804923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera.
    Stasi R; Venditti A; Del Poeta G; Conforti M; Brunetti M; Bussa S; Amadori S; Pagano A
    Am J Med Sci; 1998 Apr; 315(4):237-41. PubMed ID: 9537637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera.
    Muller EW; de Wolf JT; Egger R; Wijermans PW; Huijgens PC; Halie MR; Vellenga E
    Br J Haematol; 1995 Feb; 89(2):313-8. PubMed ID: 7873381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
    Them NC; Bagienski K; Berg T; Gisslinger B; Schalling M; Chen D; Buxhofer-Ausch V; Thaler J; Schloegl E; Gastl GA; Wolf D; Strecker K; Egle A; Melchardt T; Burgstaller S; Willenbacher E; Zagrijtschuk O; Klade C; Greil R; Gisslinger H; Kralovics R
    Am J Hematol; 2015 Apr; 90(4):288-94. PubMed ID: 25545244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon apha 2b for treating patients with JAK2V617F positive polycythemia vera and essential thrombocytosis.
    Zhang ZR; Duan YC
    Asian Pac J Cancer Prev; 2014; 15(4):1681-4. PubMed ID: 24641389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.